AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yoshida, O.
Right arrow Articles by Bryan, G. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yoshida, O.
Right arrow Articles by Bryan, G. T.
Agricola
Right arrow Articles by Yoshida, O.
Right arrow Articles by Bryan, G. T.

American Journal of Clinical Nutrition, Vol 24, 848-851, Copyright © 1971 by The American Society for Clinical Nutrition, Inc.

A possible role of urinary metabolites of tryptophan in the heterotopic recurrence of bladder cancer in man

Osamu Yoshida M.D.1, Raymond R. Brown Ph.D.1, and George T. Bryan M.D., Ph.D.1

1 From The Division of Clinical Oncology, University of Wisconsin Medical School, Madison, Wisconsin 53706

The following conclusions appear justified. Relative to clinical studies on tryptophan metabolism in patients with bladder tumors, considerable evidence has been accumulated to support the tryptophan metabolite-bladder cancer hypothesis; no evidence has been shown to refute this hypothesis. As there is the relationship between tryptophan metabolism and heterotopic recurrences of human bladder cancer, clinical trials should be made to further substantiate this and to ascertain if vitamin B6 administration might retard the development of these recurrences.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1971 by The American Society for Nutrition